Speaker illustration

Doctor Michal Kerekanic

East-Slovak Institute of Cardiovascular Diseases, Kosice (Slovakia)

The follow-up of patients with chronic heart failure and implantable cardioverter defibrillator in primary prevention

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Device Therapy

Thumbnail

The significance of NT-proBNP plasma concentration at baseline for predicting outcomes after CRT-D implantation in heart failure patients

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy

Thumbnail

The impact of cardiac resynchronization therapy on serum levels of high sensitivity C-reactive protein in patients with chronic heart failure

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Results (Resynchronization therapy)

Session: Cardiac resynchronisation therapy

Thumbnail

This platform is supported by

logo Novo Nordisk